Title 20 — Title 20: Professional and Occupational Licensing, Certification, Title Protection and Registration. Examining Boards

Sec. 20-617a. Flavoring agent added to prescription product. Exemptions. (a) For purposes of this section, “flavoring agent” means an additive used in food or drugs when such additive (1) is used in accordance with good manufacturing practice principles and in the minimum quantit…

Sec. 20-617b. Compliance packaging. Requirements. Regulations. (a)(1) A pharmacist or advanced pharmacy technician may, at the request of a patient, the patient's representative or the patient's prescribing practitioner, dispense to the patient compatible drugs in compliance pack…

Sec. 20-618. (Formerly Sec. 21a-107). Repackaged drugs not considered misbranded, when. Notwithstanding the provisions of section 21a-106 concerning misbranding of drugs or devices, a drug shall not be considered misbranded when repackaged by a pharmacy or an institutional pharma…

Sec. 20-619. (Formerly Sec. 20-185a). Substitution of generic drugs and biological products. Definitions. Interchangeable biological products. Prescribing practitioners. Pharmacy signs. Dispensing. Records. Regulations. (a) For the purposes of section 20-579 and this section: (1)…

Sec. 20-619a. Biological product prescribing. Prescribing practitioner discussion with patient or representative. Documentation. Patient request to sign for delivery. (a) Prior to prescribing a biological product, as defined in section 20-619, a prescribing practitioner shall dis…

Sec. 20-620. (Formerly Sec. 20-185g). Pharmacist's duties towards Medicaid recipients: To obtain, record and maintain pertinent patient information about the recipient; to undertake a review of the drugs previously dispensed to the recipient and to offer to discuss the drugs to b…

Sec. 20-621. (Formerly Sec. 20-185h). Relabeling and dispensing of parenteral medication in hospital and nursing home pharmacies: When allowed. A pharmacist practicing in a hospital pharmacy or nursing home pharmacy may relabel and dispense to a registered inpatient, parenteral m…

Sec. 20-621a. Use of automated prescription dispensing machine in long-term care pharmacies authorized. Regulations. (a) As used in this section: (1) “Long-term care pharmacy” (A) means a pharmacy licensed under section 20-594, or registered as a nonresident pharmacy under sectio…

Sec. 20-622. (Formerly Sec. 20-180a). Licensed practitioners may authorize medication to be dispensed from a hospital emergency room. When the therapeutic needs of a patient require that medication be initiated immediately and the services of a licensed pharmacy are not available…

Sec. 20-623. Sale of nonlegend drugs, nonlegend devices and test strips. Labels, packaging, contents and vending machines. Penalty. (a) No nonlegend drug may be sold at retail except at a pharmacy, at a store or in a vending machine that is owned and operated by a business that h…

Sec. 20-624. Permit to sell nonlegend drugs. (a) Any person may apply to the commission for a permit to sell nonlegend drugs. (b) The commission may, in accordance with regulations adopted under sections 20-570 to 20-630, inclusive, in accordance with chapter 54, and on payment o…

Sec. 20-625. Nonlegend veterinary drugs. Nothing in sections 20-570 to 20-630, inclusive, shall be construed to prohibit the sale of veterinary drugs that are nonlegend drugs by any person who holds a permit to sell nonlegend drugs. (P.A. 95-264, S. 44; P.A. 99-175, S. 43.) Histo…

Sec. 20-626. Confidentiality of pharmacy records. (a) No pharmacist or pharmacy shall reveal any records or information concerning the nature of pharmaceutical services rendered to a patient without the oral or written consent of the patient or the patient's agent. If a patient o…

Sec. 20-627. Nonresident pharmacy. Definitions. Certificate of registration. Requirements. (a) As used in sections 20-627 to 20-630, inclusive, “nonresident pharmacy” means any pharmacy located outside this state that ships, mails or delivers, in any manner, legend devices or leg…

Sec. 20-628. Shipping, mailing or delivering legend devices or drugs. No nonresident pharmacy shall engage in the business of shipping, mailing or delivering legend devices or legend drugs in this state unless such nonresident pharmacy has been issued a certificate of registratio…

Sec. 20-629. Denial, revocation or suspension of nonresident pharmacy certificate of registration. Referral by commission. (a) The commission may deny, revoke or suspend any certificate of registration as a nonresident pharmacy for: (1) Failure to comply with any requirement of t…

Sec. 20-630. Advertising. It shall be unlawful for any nonresident pharmacy which has not been issued a certificate of registration pursuant to section 20-628 to advertise its services in this state, or for any person who is a resident of this state to advertise the pharmacy serv…

Sec. 20-631. Collaborative drug therapy care plans, management agreements and policies. Scope. Care-giving institutions, devices and qualified pharmacists. Regulations. (a) For the purposes of this section: (1) “Care-giving institution” has the same meaning as provided in section…

Sec. 20-631a. Collaborative drug management agreements between pharmacists employed by community pharmacies and one or more physicians or advanced practice registered nurses. Pilot program. (a) Not later than January 1, 2006, the Commissioner of Consumer Protection, in consultati…

Sec. 20-631b. Collaborative drug therapy management agreements entered into prior to October 1, 2010. The provisions of section 20-631 in effect on September 30, 2010, shall apply to any written protocol-based collaborative drug therapy management agreement entered into prior to …

Sec. 20-632. Regulatory action report re disciplinary action against persons with controlled substance registrations and sanctions against pharmacists or pharmacies. Not less than once every three months, the Department of Consumer Protection shall compile a regulatory action rep…

Sec. 20-633. Administration of vaccines and epinephrine cartridge injectors by pharmacists and pharmacy technicians. Disclosures. Training. Recordkeeping. Regulations. (a)(1) Any person licensed as a pharmacist under part II of this chapter may order, prescribe and administer: (A…

Sec. 20-633a. Pharmacy rewards program. Plain language summary. Violation. (a) For purposes of this section: (1) “Pharmacy rewards program” means a promotional arrangement under which a retailer provides a consumer with store credits, discounts or other tangible benefits in excha…

Sec. 20-633b. Sterile compounding pharmacies. Sterile compounding by health care institutions. Requirements. Exemption. Regulations. (a) As used in this section: (1) “Medical order” means a written, oral or electronic order by a prescribing practitioner for a drug to be dispensed…

Sec. 20-633c. Prescribing of opioid antagonists by licensed pharmacists. Regulations. (a) A person who is licensed as a pharmacist under part II of this chapter and is certified in accordance with subsection (b) of this section may prescribe, in good faith, an opioid antagonist, …

Sec. 20-633d. Medical protocol standing order for dispensing of opioid antagonists by licensed pharmacists. Regulations. (a) A prescribing practitioner, as defined in section 20-14c, who is authorized to prescribe an opioid antagonist, as defined in section 17a-714a, and a pharma…

Sec. 20-633e. Pharmacy and institutional pharmacy perpetual inventory of Schedule II controlled substances. Regulations. (a) As used in this section, “pharmacy” and “institutional pharmacy” have the same meanings as provided in section 20-571. (b) Each pharmacy and institutional …

Sec. 20-633f. Ordering and administration of COVID-19-related, HIV-related and influenza-related tests, and prescribing of HIV-related prophylaxes, by licensed pharmacists. Delegation to advanced pharmacy technicians. Recordkeeping. Confidentiality. Disclosure. Regulations. (a) F…

Sec. 20-633g. Operation of mobile pharmacies by licensed pharmacies. Application. Recordkeeping. Operations. Regulations. (a)(1) A pharmacy may apply to the department, in a form and manner prescribed by the commissioner, to operate a mobile pharmacy in a temporary location for t…

Sec. 20-633h. Unscheduled closings by licensed pharmacies. Plan. Disclosures. Prescription transfers. Regulations. (a) For the purposes of this section, “pharmacy district manager” means an individual who (1) supervises at least three pharmacies within this state, and (2) is resp…

Sec. 20-633i. Issuance of prescriptions for epinephrine auto injectors by pharmacists. (a) For purposes of this section, “epinephrine auto injector” means a prefilled auto injector or similar automatic injectable equipment used to deliver epinephrine in a standard dose for emerge…

Sec. 20-633j. Authorization, refilling and dispensing of legend devices by licensed pharmacists. Notice to prescribing practitioner. (a) For the purposes of this section, “drug”, “legend device”, “pharmacist” and “prescribing practitioner” have the same meanings as provided in se…

Sec. 20-633k. Prescribing of emergency and hormonal contraceptives by licensed pharmacists. Training. Patient screening. Disclosures and notices. Assistance by pharmacy technicians. Recordkeeping. Regulations. (a) For the purposes of this section: (1) “Department” means the Depar…

Sec. 20-633l. Disclosure of information by licensed pharmacists regarding drugs used for termination of pregnancy. Prohibition concerning automatic reciprocal jurisdiction. (a) For the purposes of this section, “drug”, “pharmacist” and “pharmacy” have the same meanings as provide…

Sec. 20-633m. Provision of information concerning personal opioid drug deactivation and disposal system at time of dispensing of an opioid drug. (a) As used in this section: (1) “Dispense” has the same meaning as provided in section 21a-240; (2) “Opioid drug” has the same meaning…

Sec. 20-634. Dispensing group practices and dispensing assistants. Registration. Fees. Exemptions. Prohibitions. Penalties. (a) For the purposes of this section: (1) “Centralized dispensing practitioner” means a prescribing practitioner (A) who is employed by, or affiliated with,…

Sec. 20-635. Prescription error reporting. Definitions. Informational signs and statements. Regulations. Nondisclosure of records. (a) As used in this section: (1) “Dispensing” means those acts of processing a drug for delivery or for administration for a patient pursuant to a pr…

Sec. 20-636. Sign re storage and disposal of prescription drugs. Sticker or label on container or packaging. (a) Each pharmacy, as defined in section 20-635, shall post a sign in a conspicuous place on the premises of such pharmacy, notifying consumers that they may visit the Int…

Sec. 20-637. Reserved for future use. PART V ASSISTANCE PROGRAM AND PETITIONS CONCERNINGSAFE AND SKILLFUL PRACTICE

Sec. 20-638. Definitions. As used in this section and sections 20-638a to 20-638c, inclusive: (1) “Assistance program” has the same meaning as provided in subsection (a) of section 19a-12a; (2) “Chemical dependency” has the same meaning as provided in subsection (a) of section 19…

Sec. 20-638a. Admission of pharmacists and pharmacy interns. Referral to department. Notification of disciplinary action against program participants. Recordkeeping and confidentiality. Annual reports and audit. (a) Any pharmacist or pharmacy intern may access the assistance prog…

Sec. 20-638b. Petition re inability of pharmacist or pharmacy intern to practice with reasonable skill or safety. Report re arrest or disciplinary action. Investigation. Disclosure. Procedure. (a)(1) Any health care professional, hospital, pharmacy, pharmacist or pharmacy intern …

Sec. 20-638c. Pharmacy professional assistance program account. There is established an account to be known as the “pharmacy professional assistance program account” which shall be a separate, nonlapsing account within the General Fund. The account shall contain any moneys requir…

Sec. 20-639. Reserved for future use.